GRI GRI Bio Inc

Price (delayed)

$1.45

Market cap

$2.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$50.91

Enterprise value

-$8.42M

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
GRI Bio's EPS has soared by 97% YoY and by 58% from the previous quarter
The equity has soared by 76% from the previous quarter
The net income has contracted by 16% YoY but it has grown by 9% from the previous quarter

Key stats

What are the main financial stats of GRI

GRI stock price

How has the GRI Bio stock price performed over time
Intraday
-3.33%
1 week
-3.33%
1 month
-21.2%
1 year
-97.37%
YTD
-79.02%
QTD
-18.08%

Financial performance

How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.93M
Net income
-$10.91M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 16% YoY but it has grown by 9% from the previous quarter
GRI Bio's operating income has decreased by 16% YoY but it has increased by 9% from the previous quarter

Price vs fundamentals

How does GRI's price correlate with its fundamentals

Growth

What is GRI Bio's growth rate over time

Valuation

What is GRI Bio stock price valuation
P/E
N/A
P/B
0.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has soared by 97% YoY and by 58% from the previous quarter
The price to book (P/B) is 98% lower than the 5-year quarterly average of 10.4 and 80% lower than the last 4 quarters average of 1.0
The equity has soared by 76% from the previous quarter

Efficiency

How efficient is GRI Bio business performance
GRI's ROE is up by 48% QoQ and by 40% YoY
The company's return on assets rose by 31% QoQ and by 29% YoY

Dividends

What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRI.

Financial health

How did GRI Bio financials performed over time
GRI's total assets has soared by 181% YoY and by 31% from the previous quarter
GRI's total liabilities has dropped by 72% year-on-year and by 70% since the previous quarter
GRI Bio's debt is 99% less than its equity
GRI's debt to equity has plunged by 89% YoY
The equity has soared by 76% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.